HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
276
Capricor Therapeutics
CAPR
$296M
|
JP
Joseph Pantginis
| $6.48 | $24 |
270%
upside
| Buy |
11 Jul ‘25
2 months ago |
|
277
KalVista Pharmaceuticals
KALV
$786M
|
AF
Andrew Fein
| $15.61 | $27 |
73%
upside
| Buy |
11 Jul ‘25
2 months ago |
|
|
KZIA
278
Kazia Therapeutics
KZIA
$9M
|
SL
Sean Lee
| $8.05 | $13 |
61%
upside
| Buy |
10 Jul ‘25
2 months ago |
|
|
USAS
279
Americas Gold and Silver
USAS
$736M
|
HI
Heiko Ihle
| $2.71 | $3.25 |
20%
upside
| Buy |
10 Jul ‘25
2 months ago |
|
280
RAPT Therapeutics
RAPT
$225M
|
EB
Emily Bodnar
| $13.60 | $27 |
99%
upside
| Buy |
10 Jul ‘25
2 months ago |
|
281
First Majestic Silver
AG
$4.47B
|
HI
Heiko Ihle
| $9.14 | $12.75 |
40%
upside
| Buy |
10 Jul ‘25
2 months ago |
|
|
EXK
282
Endeavour Silver
EXK
$1.71B
|
HI
Heiko Ihle
| $5.89 | $8.75 |
49%
upside
| Buy |
9 Jul ‘25
2 months ago |
|
|
IMAB
283
I-MAB
IMAB
$376M
|
AM
Andres Maldonado
| $4.60 | $7 |
52%
upside
| Buy |
9 Jul ‘25
2 months ago |
|
284
Senseonics Holdings
SENS
$362M
|
SL
Sean Lee
| $0.4440 | $1.40 |
215%
upside
| Buy |
8 Jul ‘25
2 months ago |
|
285
Jasper Therapeutics
JSPR
$42.1M
|
EB
Emily Bodnar
| $2.59 | $20 |
672%
upside
| Buy |
7 Jul ‘25
2 months ago |
|
|
NAK
286
Northern Dynasty Minerals
NAK
$450M
|
HI
Heiko Ihle
| $0.8149 | $2.50 |
207%
upside
| Buy |
7 Jul ‘25
2 months ago |
|
287
Gain Therapeutics
GANX
$61.5M
|
RS
Raghuram Selvaraju
| $1.71 | $8 |
368%
upside
| Buy |
3 Jul ‘25
2 months ago |
|
288
Disc Medicine
IRON
$2.1B
|
DT
Douglas Tsao
| $60.34 | $118 |
96%
upside
| Buy |
3 Jul ‘25
2 months ago |
|
|
MOGO
289
Mogo
MOGO
$42.1M
|
SB
Scott Buck
| $1.77 | $4 |
126%
upside
| Buy |
3 Jul ‘25
2 months ago |
|
|
NB
290
NioCorp Developments
NB
$308M
|
HI
Heiko Ihle
| $4.24 | $4 |
6%
downside
| Buy |
3 Jul ‘25
2 months ago |
|
|
BLTE
291
Belite Bio
BLTE
$2.16B
|
YC
Yi Chen
| $65.68 | $100 |
52%
upside
| Buy |
3 Jul ‘25
2 months ago |
|
292
Zymeworks
ZYME
$1.15B
|
RB
Robert Burns
| $15.23 | $13 |
15%
downside
| Neutral |
3 Jul ‘25
2 months ago |
|
|
TLX
293
Telix Pharmaceuticals Limited American Depositary Shares
TLX
$3.11B
|
RB
Robert Burns
| $9.29 | $23 |
148%
upside
| Buy |
3 Jul ‘25
2 months ago |
|
294
Enliven Therapeutics
ELVN
$1.17B
|
RB
Robert Burns
| $19.72 | $48 |
143%
upside
| Buy |
2 Jul ‘25
2 months ago |
|
295
Zevra Therapeutics
ZVRA
$461M
|
BF
Brandon Folkes
| $8.21 | $26 |
217%
upside
| Buy |
2 Jul ‘25
2 months ago |
|
296
Tyra Biosciences
TYRA
$630M
|
MK
Mitchell Kapoor
| $11.82 | $30 |
154%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
297
Summit Therapeutics
SMMT
$14B
|
MK
Mitchell Kapoor
| $18.82 | $44 |
134%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
298
PDS Biotechnology
PDSB
$55.5M
|
JP
Joseph Pantginis
| $1.18 | $13 |
1,002%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
299
NextCure
NXTC
$13.6M
|
EB
Emily Bodnar
| $5.07 | $36 |
610%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
300
Candel Therapeutics
CADL
$273M
|
AF
Andrew Fein
| $4.97 | $23 |
363%
upside
| Buy |
30 Jun ‘25
2 months ago |
|